Time series gene expression profiling and temporal regulatory pathway analysis of BMP6 induced osteoblast differentiation and mineralization

BMC Systems Biology

Volumn 5, Issue , 2011, Pages

  Luo, Weijun ^a,b   Friedman, Michael S ^c   Hankenson, Kurt D ^d   Woolf, Peter J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^c Thermogenesis Corp   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BMP6 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN 6; NOTCH RECEPTOR;

ALGORITHM; ARTICLE; BIOLOGICAL MODEL; BIOLOGY; CELL DIFFERENTIATION; CYTOLOGY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; METHODOLOGY; OSTEOBLAST; SIGNAL TRANSDUCTION; STATISTICAL MODEL; SYSTEMS BIOLOGY; TIME;

ALGORITHMS; BONE MORPHOGENETIC PROTEIN 6; CELL DIFFERENTIATION; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MODELS, BIOLOGICAL; MODELS, GENETIC; MODELS, STATISTICAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOBLASTS; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; TIME FACTORS;

EID: 79956216833     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-5-82     Document Type: Article

References (65)

1. Harada S, Rodan GA. Control of osteoblast function and regulation of bone mass. Nature 2003, 423:349-55. 10.1038/nature01660, 12748654.
2. Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth Factors 2004, 22:233-41. 10.1080/08977190412331279890, 15621726.
3. Li X, Cao X. BMP signaling and skeletogenesis. Ann N Y Acad Sci 2006, 1068:26-40. 10.1196/annals.1346.006, 16831903.
4. Lavery KS, Swain PM, Falb D, Alaoui-Ismaili MH. BMP-2/4 and BMP-6/7 differentially utilize cell surface receptors to induce osteoblastic differentiation of human bone marrow derived mesenchymal stem cells. J Biol Chem 2008,
5. Friedman MS, Long MW, Hankenson KD. Osteogenic differentiation of human mesenchymal stem cells is regulated by bone morphogenetic protein-6. J Cell Biochem 2006, 98:538-54. 10.1002/jcb.20719, 16317727.
6. de Jong DS, Vaes BL, Dechering KJ, Feijen A, Hendriks JM, Wehrens R, Mummery CL, van Zoelen EJ, Olijve W, Steegenga WT. Identification of novel regulators associated with early-phase osteoblast differentiation. J Bone Miner Res 2004, 19:947-58. 10.1359/JBMR.040216, 15125793.
7. Peng Y, Kang Q, Cheng H, Li X, Sun MH, Jiang W, Luu HH, Park JY, Haydon RC, He TC. Transcriptional characterization of bone morphogenetic proteins (BMPs)-mediated osteogenic signaling. J Cell Biochem 2003, 90:1149-65. 10.1002/jcb.10744, 14635189.
8. Harris SE, Guo D, Harris MA, Krishnaswamy A, Lichtler A. Transcriptional regulation of BMP-2 activated genes in osteoblasts using gene expression microarray analysis: role of Dlx2 and Dlx5 transcription factors. Front Biosci 2003, 8:s1249-65. 10.2741/1170, 12957859.
9. Korchynskyi O, Dechering KJ, Sijbers AM, Olijve W, ten Dijke P. Gene array analysis of bone morphogenetic protein type I receptor-induced osteoblast differentiation. J Bone Miner Res 2003, 18:1177-85. 10.1359/jbmr.2003.18.7.1177, 12854827.
10. Kalajzic I, Staal A, Yang WP, Wu Y, Johnson SE, Feyen JH, Krueger W, Maye P, Yu F, Zhao Y, Kuo L, Gupta RR, Achenie LE, Wang HW, Shin DG, Rowe DW. Expression profile of osteoblast lineage at defined stages of differentiation. J Biol Chem 2005, 280:24618-26. 10.1074/jbc.M413834200, 15834136.
11. de Jong DS, Steegenga WT, Hendriks JM, van Zoelen EJ, Olijve W, Dechering KJ. Regulation of Notch signaling genes during BMP2-induced differentiation of osteoblast precursor cells. Biochem Biophys Res Commun 2004, 320:100-7. 10.1016/j.bbrc.2004.05.150, 15207708.
12. Balint E, Lapointe D, Drissi H, van der Meijden C, Young DW, van Wijnen AJ, Stein JL, Stein GS, Lian JB. Phenotype discovery by gene expression profiling: mapping of biological processes linked to BMP-2-mediated osteoblast differentiation. J Cell Biochem 2003, 89:401-26. 10.1002/jcb.10515, 12704803.
13. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005, 102:15545-50. 10.1073/pnas.0506580102, 1239896, 16199517.
14. Kelder T, Conklin BR, Evelo CT, Pico AR. Finding the right questions: exploratory pathway analysis to enhance biological discovery in large datasets. PLoS Biol 2010, 8:e1000472. 10.1371/journal.pbio.1000472, 2930872, 20824171.
15. Davies MN, Meaburn EL, Schalkwyk LC. Gene set enrichment; a problem of pathways. Brief Funct Genomics 9:385-90.
16. Nam D, Kim SY. Gene-set approach for expression pattern analysis. Brief Bioinform 2008, 9:189-97. 10.1093/bib/bbn001, 18202032.
17. Kleemann R, van Erk M, Verschuren L, van den Hoek AM, Koek M, Wielinga PY, Jie A, Pellis L, Bobeldijk-Pastorova I, Kelder T, Toet K, Wopereis S, Cnubben N, Evelo C, van Ommen B, Kooistra T. Time-resolved and tissue-specific systems analysis of the pathogenesis of insulin resistance. PLoS One 5:e8817.
18. Luo W, Friedman MS, Shedden K, Hankenson KD, Woolf PJ. GAGE: generally applicable gene set enrichment for pathway analysis. BMC Bioinformatics 2009, 10:161. 10.1186/1471-2105-10-161, 2696452, 19473525.
19. Gosselet FP, Magnaldo T, Culerrier RM, Sarasin A, Ehrhart JC. BMP2 and BMP6 control p57(Kip2) expression and cell growth arrest/terminal differentiation in normal primary human epidermal keratinocytes. Cell Signal 2007, 19:731-9. 10.1016/j.cellsig.2006.09.006, 17112701.
20. Kim JB, Leucht P, Luppen CA, Park YJ, Beggs HE, Damsky CH, Helms JA. Reconciling the roles of FAK in osteoblast differentiation, osteoclast remodeling, and bone regeneration. Bone 2007, 41:39-51. 10.1016/j.bone.2007.01.024, 2699353, 17459803.
21. Salasznyk RM, Klees RF, Williams WA, Boskey A, Plopper GE. Focal adhesion kinase signaling pathways regulate the osteogenic differentiation of human mesenchymal stem cells. Exp Cell Res 2007, 313:22-37. 10.1016/j.yexcr.2006.09.013, 1780174, 17081517.
22. Ulsamer A, Ortuno MJ, Ruiz S, Susperregui AR, Osses N, Rosa JL, Ventura F. BMP-2 induces Osterix expression through up-regulation of Dlx5 and its phosphorylation by p38. J Biol Chem 2008, 283:3816-26.
23. Celil AB, Campbell PG. BMP-2 and insulin-like growth factor-I mediate Osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways. J Biol Chem 2005, 280:31353-9. 10.1074/jbc.M503845200, 16000303.
24. KEGG: Kyoto Encyclopedia of Genes and Genomes. , http://www.genome.jp/kegg/
25. Nobta M, Tsukazaki T, Shibata Y, Xin C, Moriishi T, Sakano S, Shindo H, Yamaguchi A. Critical regulation of bone morphogenetic protein-induced osteoblastic differentiation by Delta1/Jagged1-activated Notch1 signaling. J Biol Chem 2005, 280:1584-8.
26. Zhao G, Monier-Faugere MC, Langub MC, Geng Z, Nakayama T, Pike JW, Chernausek SD, Rosen CJ, Donahue LR, Malluche HH, Fagin JA, Clemens TL. Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation. Endocrinology 2000, 141:2674-82. 10.1210/en.141.7.2674, 10875273.
27. Zhang M, Xuan S, Bouxsein ML, von Stechow D, Akeno N, Faugere MC, Malluche H, Zhao G, Rosen CJ, Efstratiadis A, Clemens TL. Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J Biol Chem 2002, 277:44005-12. 10.1074/jbc.M208265200, 12215457.
28. Strohbach C, Kleinman S, Linkhart T, Amaar Y, Chen ST, Mohan S, Strong D. Potential involvement of the interaction between insulin-like growth factor binding protein (IGFBP)-6 and LIM mineralization protein (LMP)-1 in regulating osteoblast differentiation. J Cell Biochem 2008,
29. Mukherjee A, Rotwein P. Insulin-like growth factor-binding protein-5 inhibits osteoblast differentiation and skeletal growth by blocking insulin-like growth factor actions. Mol Endocrinol 2008, 22:1238-50. 10.1210/me.2008-0001, 2366187, 18292241.
30. Silha JV, Mishra S, Rosen CJ, Beamer WG, Turner RT, Powell DR, Murphy LJ. Perturbations in bone formation and resorption in insulin-like growth factor binding protein-3 transgenic mice. J Bone Miner Res 2003, 18:1834-41. 10.1359/jbmr.2003.18.10.1834, 14584894.
31. Zhang M, Faugere MC, Malluche H, Rosen CJ, Chernausek SD, Clemens TL. Paracrine overexpression of IGFBP-4 in osteoblasts of transgenic mice decreases bone turnover and causes global growth retardation. J Bone Miner Res 2003, 18:836-43. 10.1359/jbmr.2003.18.5.836, 12733722.
32. Arron JR, Choi Y. Bone versus immune system. Nature 2000, 408:535-6. 10.1038/35046196, 11117729.
33. Walsh MC, Kim N, Kadono Y, Rho J, Lee SY, Lorenzo J, Choi Y. Osteoimmunology: interplay between the immune system and bone metabolism. Annu Rev Immunol 2006, 24:33-63. 10.1146/annurev.immunol.24.021605.090646, 16551243.
34. Arai F, Ohneda O, Miyamoto T, Zhang XQ, Suda T. Mesenchymal stem cells in perichondrium express activated leukocyte cell adhesion molecule and participate in bone marrow formation. J Exp Med 2002, 195:1549-63. 10.1084/jem.20011700, 2193567, 12070283.
35. Bennett KP, Bergeron C, Acar E, Klees RF, Vandenberg SL, Yener B, Plopper GE. Proteomics reveals multiple routes to the osteogenic phenotype in mesenchymal stem cells. BMC Genomics 2007, 8:380. 10.1186/1471-2164-8-380, 2148065, 17949499.
36. Ebert R, Jakob F. Selenium deficiency as a putative risk factor for osteoporosis. International Congress Series: Nutritional Aspects of Osteoporosis 2006. Proceedings of the 6th International Symposium on Nutritional Aspects of Osteoporosis, 4-6 May 2006, Lausanne, Switzerland 2007, 1297:158-164.
37. Kanei-Ishii C, Ninomiya-Tsuji J, Tanikawa J, Nomura T, Ishitani T, Kishida S, Kokura K, Kurahashi T, Ichikawa-Iwata E, Kim Y, Matsumoto K, Ishii S. Wnt-1 signal induces phosphorylation and degradation of c-Myb protein via TAK1, HIPK2, and NLK. Genes Dev 2004, 18:816-29. 10.1101/gad.1170604, 387421, 15082531.
38. Nair M, Bilanchone V, Ortt K, Sinha S, Dai X. Ovol1 represses its own transcription by competing with transcription activator c-Myb and by recruiting histone deacetylase activity. Nucleic Acids Res 2007, 35:1687-97. 10.1093/nar/gkl1141, 1865076, 17311813.
39. Garcia-Pedrero JM, Kiskinis E, Parker MG, Belandia B. The SWI/SNF chromatin remodeling subunit BAF57 is a critical regulator of estrogen receptor function in breast cancer cells. J Biol Chem 2006, 281:22656-64. 10.1074/jbc.M602561200, 16769725.
40. Villagra A, Cruzat F, Carvallo L, Paredes R, Olate J, van Wijnen AJ, Stein GS, Lian JB, Stein JL, Imbalzano AN, Montecino M. Chromatin remodeling and transcriptional activity of the bone-specific osteocalcin gene require CCAAT/enhancer-binding protein beta-dependent recruitment of SWI/SNF activity. J Biol Chem 2006, 281:22695-706. 10.1074/jbc.M511640200, 16772287.
41. Colland F, Jacq X, Trouplin V, Mougin C, Groizeleau C, Hamburger A, Meil A, Wojcik J, Legrain P, Gauthier JM. Functional proteomics mapping of a human signaling pathway. Genome Res 2004, 14:1324-32. 10.1101/gr.2334104, 442148, 15231748.
42. Simone C, Forcales SV, Hill DA, Imbalzano AN, Latella L, Puri PL. p38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci. Nat Genet 2004, 36:738-43. 10.1038/ng1378, 15208625.
43. Lutwyche JK, Keough RA, Hunter J, Coles LS, Gonda TJ. DNA binding-independent transcriptional activation of the vascular endothelial growth factor gene (VEGF) by the Myb oncoprotein. Biochem Biophys Res Commun 2006, 344:1300-7. 10.1016/j.bbrc.2006.04.045, 16650815.
44. Itoh F, Itoh S, Goumans MJ, Valdimarsdottir G, Iso T, Dotto GP, Hamamori Y, Kedes L, Kato M, ten Dijke Pt P. Synergy and antagonism between Notch and BMP receptor signaling pathways in endothelial cells. Embo J 2004, 23:541-51. 10.1038/sj.emboj.7600065, 1271801, 14739937.
45. Dahlqvist C, Blokzijl A, Chapman G, Falk A, Dannaeus K, Ibanez CF, Lendahl U. Functional Notch signaling is required for BMP4-induced inhibition of myogenic differentiation. Development 2003, 130:6089-99. 10.1242/dev.00834, 14597575.
46. Takizawa T, Ochiai W, Nakashima K, Taga T. Enhanced gene activation by Notch and BMP signaling cross-talk. Nucleic Acids Res 2003, 31:5723-31. 10.1093/nar/gkg778, 206475, 14500836.
47. Deregowski V, Gazzerro E, Priest L, Rydziel S, Canalis E. Notch 1 overexpression inhibits osteoblastogenesis by suppressing Wnt/beta-catenin but not bone morphogenetic protein signaling. J Biol Chem 2006, 281:6203-10. 10.1074/jbc.M508370200, 16407293.
48. Leroith D, Nissley P. Knock your SOCS off!. J Clin Invest 2005, 115:233-6. 546429, 15690080.
49. Hochreiter S, Clevert DA, Obermayer K. A new summarization method for Affymetrix probe level data. Bioinformatics 2006, 22:943-9. 10.1093/bioinformatics/btl033, 16473874.
50. Gene Ontology. , http://www.geneontology.org/
51. The Molecular Signature Database. , http://www.broad.mit.edu/gsea/msigdb/
52. Horan K, Jang C, Bailey-Serres J, Mittler R, Shelton C, Harper JF, Zhu JK, Cushman JC, Gollery M, Girke T. Annotating genes of known and unknown function by large-scale coexpression analysis. Plant Physiol 2008, 147:41-57. 10.1104/pp.108.117366, 2330292, 18354039.
53. Allocco DJ, Kohane IS, Butte AJ. Quantifying the relationship between co-expression, co-regulation and gene function. BMC Bioinformatics 2004, 5:18. 10.1186/1471-2105-5-18, 375525, 15053845.
54. Al-Shahrour F, Diaz-Uriarte R, Dopazo J. FatiGO: a web tool for finding significant associations of Gene Ontology terms with groups of genes. Bioinformatics 2004, 20:578-80. 10.1093/bioinformatics/btg455, 14990455.
55. Zhang B, Schmoyer D, Kirov S, Snoddy J. GOTree Machine (GOTM): a web-based platform for interpreting sets of interesting genes using Gene Ontology hierarchies. BMC Bioinformatics 2004, 5:16. 10.1186/1471-2105-5-16, 373441, 14975175.
56. Adler P, Reimand J, Janes J, Kolde R, Peterson H, Vilo J. KEGGanim: pathway animations for high-throughput data. Bioinformatics 2008, 24:588-90. 10.1093/bioinformatics/btm581, 18056068.
57. Hughes FJ, Collyer J, Stanfield M, Goodman SA. The effects of bone morphogenetic protein-2, -4, and -6 on differentiation of rat osteoblast cells in vitro. Endocrinology 1995, 136:2671-7. 10.1210/en.136.6.2671, 7750491.
58. Takayanagi H, Sato K, Takaoka A, Taniguchi T. Interplay between interferon and other cytokine systems in bone metabolism. Immunol Rev 2005, 208:181-93. 10.1111/j.0105-2896.2005.00337.x, 16313349.
59. Fujita K, Janz S. Attenuation of WNT signaling by DKK-1 and -2 regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF. Mol Cancer 2007, 6:71. 10.1186/1476-4598-6-71, 2173906, 17971207.
60. Rawadi G, Vayssiere B, Dunn F, Baron R, Roman-Roman S. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res 2003, 18:1842-53. 10.1359/jbmr.2003.18.10.1842, 14584895.
61. Rajan P, Panchision DM, Newell LF, McKay RD. BMPs signal alternately through a SMAD or FRAP-STAT pathway to regulate fate choice in CNS stem cells. J Cell Biol 2003, 161:911-21. 10.1083/jcb.200211021, 2172962, 12796477.
62. Wang X, Kua HY, Hu Y, Guo K, Zeng Q, Wu Q, Ng HH, Karsenty G, de Crombrugghe B, Yeh J, Li B. p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling. J Cell Biol 2006, 172:115-25. 10.1083/jcb.200507106, 2063539, 16380437.
63. Lengner CJ, Steinman HA, Gagnon J, Smith TW, Henderson JE, Kream BE, Stein GS, Lian JB, Jones SN. Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling. J Cell Biol 2006, 172:909-21. 10.1083/jcb.200508130, 2063734, 16533949.
64. Xiao G, Gopalakrishnan R, Jiang D, Reith E, Benson MD, Franceschi RT. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. J Bone Miner Res 2002, 17:101-10. 10.1359/jbmr.2002.17.1.101, 11771655.
65. Xiao G, Wang D, Benson MD, Karsenty G, Franceschi RT. Role of the alpha2-integrin in osteoblast-specific gene expression and activation of the Osf2 transcription factor. J Biol Chem 1998, 273:32988-94. 10.1074/jbc.273.49.32988, 9830051.